Association of serum irisin with metabolic syndrome in obese chinese adults

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Yan, Bing ^a,b   Shi, Xiulin ^b   Zhang, Huijie ^b   Pan, Lingling ^c   Ma, Zhimin ^d   Liu, Suhuan ^a   Liu, Yongwen ^b   Li, Xiaoying ^a,b,c   Yang, Shuyu ^a,b   Li, Zhibin ^a,b  

^a Xiamen Diabetes Institute   (China)

^b THE FIRST AFFILIATED HOSPITAL OF XIAMEN UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; GLOBULIN; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; IRISIN; SECRETORY PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; URIC ACID; FIBRONECTIN; FNDC5 PROTEIN, HUMAN;

ADULT; ALBUMIN GLOBULIN RATIO; ALBUMINURIA; ANALYTICAL PARAMETERS; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY FAT; BODY MASS; CHINA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DRINKING BEHAVIOR; DYSLIPIDEMIA; EDUCATIONAL STATUS; FEMALE; GENDER; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; KIDNEY FUNCTION; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MUSCLE MASS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHYSICAL ACTIVITY; PROTEIN BLOOD LEVEL; RENAL SYSTEM PARAMETERS; RISK REDUCTION; SMOKING; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; URINARY ALBUMIN CREATININE RATIO; WAIST CIRCUMFERENCE; WAIST HIP RATIO; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; COMPLICATION; MIDDLE AGED;

ADIPOSITY; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; FIBRONECTINS; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY;

EID: 84899456424     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094235     Document Type: Article

References (23)

1. Eckel RH, Alberti KG, Grundy SM, Zimmet PZ (2010) The metabolic syndrome. Lancet 375:181-183.
2. Lakka HM, Laaksonen DE, Lakka TA, Nishanen LK, Kumpusalo E, et al. (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709-2716. (Pubitemid 35403784)
3. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, et al. (2004) Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in the United States adults. Circulation 110:1245-1250. (Pubitemid 39202340)
4. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, et al. (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350. (Pubitemid 32378388)
5. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, et al. (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403. (Pubitemid 34437694)
6. Yamaoka K, Tango T (2012) Effects of lifestyle modification on metabolic syndrome: a systematic review and meta-analysis. BMC Med 10:138. doi:10.1186/1741-7015-10-138.
7. Bostrom P, Wu J, Jedrychowski MP, Korde A, Ye L, et al. (2012) A PGC1-adependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481:463-468.
8. Liu JJ, Wong MD, Toy WC, Tan CS, Liu S, et al. (2013) Lower circulating irisin is associated with type 2 diabetes mellitus. J Diabetes Complications 27:365-369.
9. Choi YK, Kim MK, Bae KH, Seo HA, Jeong JY, et al. (2013) Serum irisin levels in new-onset type 2 diabetes. Diabetes Res Clin Pract 100:96-101.
10. Moreno-Navarrete JM, Ortega F, Serrano M (2013) Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. The Journal of Clinical Endocrinology and Metabolism. 98: E769-E778.
11. Hojlund K, Bostrom P (2013) Irisin in obesity and type 2 diabetes. J Diabetes Complications 27:303-304.
12. Huh JY, Panagiotou G, Mougious V, Brinkoetter M, Vamvini MT, et al. (2012) FNDC5 and irisin in human: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 61:1725-1738.
13. Stengel A, Hofmann T, Goebel-Stengel M, Elbelt U, Kobelt P, et al. (2013) Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity-correlation with body mass index. Peptide 39:125-130.
14. Zhang HJ, Zhang XF, Ma ZM, Pan LL, Chen Z, et al. (2013) Irisin is inversely associated with intrahepatic triglyceride contents in obese adults. J Hepatol doi:pii:S0168-8278(13)00285-7.10.1016/j.jhep.2013.04.030.[Epub ahead of print].
15. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, et al. (2003) The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289:2560-2572. (Pubitemid 37430158)
16. Ma YC, Zuo L, Chen JH, Luo Q, Yu XQ, et al. (2006) Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol 17:2937-2944. (Pubitemid 44484685)
17. Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 23:469-480.
18. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, et al. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640-1645.
19. R Core Team (2013). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL http://www.Rproject.org/.
20. Timmons JA, Baar K, Davidsen PK, Atherton PJ (2012) Is irisin a human exercise gene? Nature 488:E9-E10.
21. Kahn HS, Bullard KM, Barker LE, Imperatore G (2012) Differences between adiposity indicators for predicting all-cause mortality in a representative sample of United States non-elderly adults. PLoS ONE 7:e50428.
22. Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB (2005) Comparison of abdominal adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am J Clin Nutr 8:555-563.
23. Schooling CM, Lam TH, Li ZB, Ho SY, Chan WM, et al. (2006) Obesity, physical exercise and mortality in a prospective Chinese elderly cohort: a fallacy explained. Archives of Internal Medicine 166:1498-1504. (Pubitemid 44125869)